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Abstract
Background: Chlamydophila (Chlamydia) pneumoniae is an intracellular bacterium that has been
identified within cells in areas of neuropathology found in Alzheimer disease (AD), including
endothelia, glia, and neurons. Depending on the cell type of the host, infection by C. pneumoniae
has been shown to influence apoptotic pathways in both pro- and anti-apoptotic fashions. We have
hypothesized that persistent chlamydial infection of neurons may be an important mediator of the
characteristic neuropathology observed in AD brains. Chronic and/or persistent infection of
neuronal cells with C. pneumoniae in the AD brain may affect apoptosis in cells containing chlamydial
inclusions.
Results: SK-N-MC neuroblastoma cells were infected with the respiratory strain of C. pneumoniae,
AR39 at an MOI of 1. Following infection, the cells were either untreated or treated with
staurosporine and then examined for apoptosis by labeling for nuclear fragmentation, caspase
activity, and membrane inversion as indicated by annexin V staining. C. pneumoniae infection was
maintained through 10 days post-infection. At 3 and 10 days post-infection, the infected cell
cultures appeared to inhibit or were resistant to the apoptotic process when induced by
staurosporine. This inhibition was demonstrated quantitatively by nuclear profile counts and
caspase 3/7 activity measurements.
Conclusion: These data suggest that C. pneumoniae can sustain a chronic infection in neuronal cells
by interfering with apoptosis, which may contribute to chronic inflammation in the AD brain.

Background
The mechanisms and morphological changes that underlie the apoptotic process leading to cell death have been
well-described [1,2]. In this regard, the induction of apoptosis has been shown to be important in embryonic devel-

opment and in defending against infection of a eukaryotic
host by microorganisms. Examples of the latter have been
shown for both viral and bacterial infections [3,4]. In contrast, some organisms, such as the intracellular pathogen
Chlamydia pneumoniae, have the capacity to inhibit the
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apoptotic process following infection [5-7]. This inhibition has been demonstrated in a number of different cell
types, including neutrophils [8], monocytes [9,10], epithelial cells [10-12], and microglial cells [13]. Some
Chlamydia-infected host cells are resistant to pro-apoptotic stimuli such as TNFα, Fas antibody, staurosporine,
and UV-light [6,14], and C. pneumoniae infection has been
shown to down regulate pro-apoptotic cytoplasmic proteins such as caspase-3 and cytochrome c. Intriguingly, C.
pneumoniae infection also has been shown to activate antiapoptotic proteins such as Bcl-2 and NF-κβ [15], the latter
of which is critical in the expression of multiple genes
involved in inflammatory responses and anti-apoptotic
mechanisms [16].
Our laboratory has demonstrated C. pneumoniae infection
in brain tissues from patients diagnosed with AD [17,18].
Many cell types including monocytes, endothelial cells,
glial cells and neurons were shown to be infected. Interestingly, the infected cells did not appear to be undergoing
degenerative changes, even though they were in the vicinity of cells demonstrating neurodegenerative pathology
characteristic of AD. C. pneumoniae also has been identified within neurons in the AD brain by in situ hybridization [19] as well as in the olfactory neuroepithelia, the
olfactory bulbs and endothelia from C. pneumoniaeinfected BALB/c mice by immunohistochemistry [20].
Collectively, these studies have correlated infection with
C. pneumoniae to the neuropathology characteristic of AD,
but the specific influences of infection on neuronal cell
injury, cell death, and chronic inflammation are still
being determined.

http://www.biomedcentral.com/1471-2202/9/13

Figure 1 diseased brain tissue from the hippocampal region
Alzheimer
Alzheimer diseased brain tissue from the hippocampal region. Tissue sections were labeled with an antichlamydial specific antibody revealing chlamydial inclusions
within neurons (arrows, panels A and B). (A & B) Mag. bars =
20 μm.

Immunolabeling using antibodies specific to C. pneumoniae revealed a punctate labeling pattern identifying the
chlamydial bodies within several neurons (Figure 1).
Delineation of the chlamydial bodies from lipofuscin in
the neurons was determined using a secondary antibody
conjugated to alkaline phosphatase red as compared to
the substrate diaminobenzine (DAB), since lipofuscin
and DAB typically have a brownish appearance in histological preparations.

Results

To confirm that a homogenous neuronal phenotype was
maintained in culture, SK-N-MC neuroblastoma cells
were screened with antibodies to βIII-tubulin (Figures 2A,
B), a cytoskeletal protein expressed in neuronal cells.
Quantitation yielded a homogeneous neuronal phenotype; greater than 90% of the cells labeled for βIII-tubulin.
These cells were also analyzed for any morphological
changes that may occur following incubation with 0.1%
dimethylsulfoxide (DMSO), the vehicle for the apoptotic
inducing agent staurosporine, as DMSO has been used at
higher concentrations to induce apoptosis in cultured
cells. In these control experiments, the cell's nuclear integrity did not reveal any morphological changes characteristic of apoptotic nuclear fragmentation as is evident from
the Hoechst-stained nuclear profiles (Figure 2C). Additionally, when cells were incubated with the FITC- or
rhodamine-conjugated goat anti-mouse secondary antibody without prior labeling by primary antibody, nonspecific binding of either the FITC- or rhodamine-conjugated secondary was not observed (data not shown); this
confirmed the specificity of the secondary antibodies.

Several experimental paradigms (each repeated a minimum of 3 times) were utilized in these studies to determine the relationship between C. pneumoniae infection
and apoptosis in neuronal cells as it relates to the pathogenesis of AD. C. pneumoniae was identified within neurons in hippocampal AD brain tissues (Figure 1).

In order to determine the effects exerted on the apoptotic
process by an infection with C. pneumoniae in neuronal
cells, SKNMC neuroblastoma cells were inoculated with
the respiratory strain of C. pneumoniae, AR-39, at an MOI
of 1. These cells were propagated for 3 and 10 days post-

A major factor in AD is an inflammatory process thought
to be stimulated by the processing and deposition of βamyloid (Aβ1–42). Although β-amyloid may promote
inflammation, infectious agents such as C. pneumoniae
also could provoke neuroinflammation in sporadic, lateonset AD that precedes or coincides with the deposition of
Aβ1–42 in the AD brain. The exact role that chlamydial
infection plays with respect to abnormal processing and
deposition of amyloid, however, remains to be determined and is beyond the scope of this report. In contrast,
the focus of the current study was to determine how C.
pneumoniae infection influences the apoptotic process
within neuronal cells in culture during both short and
long term infections.
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Figure antibodies
SK-N-MC
specific
2 neuroblastoma cells immunolabeled with neuronal
SK-N-MC neuroblastoma cells immunolabeled with
neuronal specific antibodies. In panels A and B, neuronal
phenotype was determined by labeling with anti-βIII-tubulin
(red). In panel C, the cells were incubated in 0.1% DMSO in
growth media for 4 hr and Hoechst-stained to highlight
nuclear profiles (blue). Mag. bars = 10 μm.

infection followed by immunolabeling with FITC-conjugated anti-chlamydial antibodies, 60C19 and Imagen
containing Evans blue staining the cytoplasm red (Figure
3). At both 3 and 10 days post-infection chlamydial inclusions were observed and the nuclei did not appear fragmented as revealed by Hoechst staining.
During apoptosis, phosphatidylserine is translocated
from the inner to the outer plasma membrane leaflet. This
externalization was analyzed with annexin V-FITC in conjunction with Hoechst staining to examine nuclear fragmentation in 3 day infected cells. In the absence of
staurosporine, uninfected cells (Figure 4A) and those
infected with C. pneumoniae (Figure 4C) showed no evidence of apoptosis by either Hoechst or annexin V staining. Staurosporine-treated, uninfected cells, however,

tion
Infection
Figure
3of neuronal cells followed by staurosporine incubaInfection of neuronal cells followed by staurosporine
incubation. SK-N-MC neuroblastoma cells infected with
Chlamydia pneumoniae for 3 days (A) and 10 days (B), revealing chlamydial inclusions (green). In panel A, Imagen antichlamydial specific antibody was used. In panel B, antichlamydial antibodies 60C19 and Imagen were used in combination to detect prolonged or persistent infection. Nuclei
were identified by Hoechst stain (blue), and the cytoplasm
was stained with Evans blue (red). Mag. bar = 10 μm.

tion Chlamydia
Annexin
with
Figure
4labelingpneumoniae
of SK-N-MC
following
neruoblastoma
staurosporine
cells infected
incubaAnnexin labeling of SK-N-MC neruoblastoma cells
infected with Chlamydia pneumoniae following staurosporine incubation. SK-N-MC neuroblastoma cells uninfected (A, B) and infected with Chlamydia pneumoniae for 3
days (C, D), untreated cells (A, C) and cells treated with 1
μM staurosporine for 4 hours (B, D), labeled with annexin V
(green) and DAPI (blue). Mag. bar = 10 μm.

showed prominent nuclear fragmentation and phosphatidylserine externalization (Figure 4B). In the case of staurosporine-treated, Chlamydia-infected neuroblastoma
cells, most nuclear profiles appeared unaffected with only
a few cells demonstrating very early apoptotic morphologic changes (Figure 4D).
Hoechst staining was used to visualize the nuclear morphology of neuroblastoma cells in which uninfected cells
and cells infected with C. pneumoniae were induced to
undergo apoptosis by staurosporine (Figure 5). Nuclear
profiles were analyzed in 20 random fields from three separate experiments (Figure 6). Uninfected cells (Figures 5A
and 6A), cells infected for 3 days (Figures 5C and 6C) and
cells infected for 10 days (Figures 5E and 6E) that had not
been exposed to staurosporine yielded minimal nuclear
fragmentation. When treated with staurosporine, 84% of
uninfected neuroblastoma cells demonstrated apoptotic
nuclear profiles (Figures 5B and 6B). In contrast, nuclear
fragmentation characteristic of apoptosis was observed in
only 47% of cells that were infected for 3 days (Figures 5D
and 6D) and 50% of cells infected for 10 days (Figures 5F
and 6F) when subsequently treated with staurosporine.
Chi-squared analysis indicated that this inhibition of
apoptosis by the infection was highly statistically significant (p < 0.0001).
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Analysis
Figure 5of the nuclear profiles of Chlamydia pneumoniae-infected neuroblastoma cells following apoptotic induction with staurosporine
Analysis of the nuclear profiles of Chlamydia pneumoniae-infected neuroblastoma cells following apoptotic
induction with staurosporine. Nuclear profiles were revealed with Hoechst stain and counted as normal or apoptotic
depending on fragmentation. Conditions in panels A-F are as follows: A, uninfected cells; B, uninfected cells treated with 1 μM
staurosporine for 4 hours; C,: cells infected for 3 days; D, cells infected for 3 days treated with 1 μM staurosporine for 4 hours;
E, cells infected for 10 days; F, cells infected for 10 days treated with 1 μM staurosporine for 4 hours. Mag. bar = 20 μm.

The effect of infection by C. pneumoniae upon the caspase
pathway in the apoptotic process was examined using
immunocytochemistry techniques. SK-N-MC neuronal
cells were infected with the AR39 strain of C. pneumoniae
and incubated with 1 μM staurosporine for 4 hours to
induce apoptosis (Figure 7), then screened for apoptosis
with an antibody specific for the activated form of caspase
3, in conjunction with Hoechst staining to reveal the
nuclear profiles. In the absence of staurosporine, uninfected SK-N-MC cells revealed a normal nuclear profile
(Figure 7A) with minimal active caspase-3, whereas uninfected cells treated with staurosporine clearly demonstrated the characteristic apoptotic nuclear fragmentation
and activated caspase 3 (Figure 7B). In cells infected with
C. pneumoniae (panels C-H), inclusion bodies were
detected by immunolabeling with a specific anti-chlamydial antibody. In non-staurosporine treated cells at 24, 48
and 72 hrs post-infection, there was virtually no visual evidence of apoptosis (Figure 7, panels C, E, G). In contrast,
in cells infected with C. pneumoniae and treated with staurosporine (Figure 7, panels D, F, H), only in the 72 hr
post-infection culture was there limited evidence of apop-

totic nuclear fragmentation and activated caspase 3 (Figure 7, panel H).
To assess whether caspase activity is inhibited by C. pneumoniae in acute or extended stages of infection, caspase
activity was quantitatively measured for uninfected cells
and cells at 24, 48 and 72 hours post-infection. The
change in caspase 3/7 activity induced by 1 μM staurosporine is plotted in Figure 8 relative to the change
observed in uninfected cells (lanes A and B). In cells
assayed at 24 hours post-infection (lanes C and D), caspase 3/7 activity in the absence of staurosporine was
slightly suppressed compared to uninfected cells, but
most notably the increase in activity induced by staurosporine was suppressed to 0.59 ± 0.08 compared to
staurosporine-treated, uninfected cells (1.00 ± 0.01). At
longer times post-infection, staurosporine induced a
larger increase in activity (0.72 ± 0.04 at 48 hr p.i., 0.70 ±
0.05 at 72 hr p.i., lanes F and H respectively), indicating
that the infection was less inhibitory at these time points,
most likely as a result of a decrease in the fraction of
infected cells in the cultures at these longer infection
times.

Page 4 of 9
(page number not for citation purposes)

BMC Neuroscience 2008, 9:13

Figure 6 analysis of nuclear profile data
Quantitative
Quantitative analysis of nuclear profile data. Lanes A-F
correspond to the conditions in panels A-F of figure 5. Data
are from 3 independent infections with 20 random fields
counted for each condition. Total cell counts are: A, 793; B,
436; C, 512; D, 412; E, 402; F, 395. Chi-squared analysis of
these data indicates that the difference between the uninfected result and the infected results (either 3 or 10 days) is
highly statistically significant (p < 0.0001), however the
infected results were not significantly different from each
other (p = 0.36)

Discussion
The current in vitro neuronal studies demonstrate that
infection of human neuroblastoma cells by C.pneumoniae has an effect on apoptosis following staurosporine
induction, as measured by characteristics of apoptosis
such as nuclear fragmentation, cytoplasmic membrane
inversion, and caspase 3/7 activation. The data suggest
that neuronal cells can develop and maintain a chronic
and prolonged infection with C.pneumoniae through 10
days post-infection. Inhibition of apoptosis was measured
from 24 hours through 10 days post-infection, and apoptosis inhibition was observed throughout this period.
However, C. pneumoniae had a more robust effect on
inhibiting apoptosis in neuronal cells at 24 hr post-infection as compared to 10 day post-infection. These results
are consistent with other studies that have determined
that C. pneumoniae infection inhibits apoptosis in monocytes [9,10], neutrophils [8], and epithelial cells [10-12].
Human neuroblastoma cell lines can be induced to
undergo apoptosis when incubated in staurosporine at
several concentrations [21]. Staurosporine is a potent
inhibitor of numerous kinases, including protein kinase C
and cAMP-dependent protein kinases [22], calmodulindependent protein kinase [23], and receptor tyrosine
kinases [24]. In cells undergoing staurosporine-induced

http://www.biomedcentral.com/1471-2202/9/13

apoptosis, levels of the pro-apoptotic protein Bax at the
mitochondrion are increased, resulting in release of cytochrome c and subsequent activation of caspase 9 and caspase 3 [25,26]. This release has been shown to be blocked
upon infection with C. pneumoniae [6]. In our studies, caspase 3/7 activity was inhibited upon infection with C.
pneumoniae, possibly resulting from inhibition of cytochrome c release. Alternatively, activation of caspase 3/7
could be inhibited by infection with C. pneumoniae downstream and/or upstream of cytochrome c release, consistent with inhibition of apoptosis at several levels of the
apoptotic mitochondrial pathway [5,6,11,12,14,27]. One
report indicated that apoptosis of endothelial cells was
indeed inhibited by infection with C. pneumoniae,
although cell death by necrosis was not [28]. Necrosis of
these cells was correlated to an increased concentration of
intracellular reactive oxygen species following infection.
Interestingly, while there is evidence for the induction of
apoptosis in the Alzheimer's diseased brain, data on the
completion of this process are questionable [29]. In AD
brains, increased levels of pro-apoptotic proteins governing mitochondrial integrity and caspase activity have been
demonstrated. These data suggest that caspase activation
may be a key factor in modulating the apoptotic process
in neurons [30]. In vitro experiments have shown that βamyloid peptides can activate the caspase cascade in neurons resulting in cell death [31-33]. However, the extent to
which neurons die in AD as a result of apoptosis remains
controversial [16].
Apoptosis is not necessarily congruent with a slow, progressive neurodegenerative disease. It is plausible that
neuronal cell death may occur through several mechanisms even though neurodegeneration may commence
along with early apoptotic events. At first glance, our
infection data appear to controvert findings of significant
neuronal degeneration and cell death. However, because
infection with C. pneumoniae can both inhibit apoptosis
and promote cell death by necrosis [28], and because we
have continually observed C. pneumoniae infection in sporadic, late-onset AD brain tissues [17-19], the possibility
that infection of neuronal cells in AD could lead to cell
death by necrosis is compelling as this would implicate
the inflammatory process. There are numerous reports of
significant neuroinflammation in AD in which cell damage and death are thought to occur as the result of inflammation [34].
Because the amount of amyloid precursor protein (APP) is
increased in areas of AD neuropathology, many studies
have focused on the cytotoxic effects of exogenous (extracellular) β-amyloid [35]. However, the role of endogenous (intracellular) β-amyloid in the neuronal cell's
viability remains a conundrum. Recently, endogenous
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Figure
tosis
SK-N-MC
with
7 staurosporine
neuroblastoma cells immunolabeled for active caspase 3 and C. pneumoniae inclusions following induction of apopSK-N-MC neuroblastoma cells immunolabeled for active caspase 3 and C. pneumoniae inclusions following
induction of apoptosis with staurosporine. Anti-caspase 3 specific for activated caspase 3 (red); DAPI to reveal the
nuclear profile (blue); anti-chlamydial antibody specific for chlamydial inclusions (green). Shown are uninfected (A, B) and
infected cells for 24 (C, D), 48 (E, F) and 72 (G, H) hours post infection, untreated cells (A, C, E, G) and cells treated with 1 μM
staurosporine for 4 hours (B, D, F, H). Mag. bar = 20 μm.

APP has been shown to have anti-apoptotic effects on cells
isolated from dorsal root ganglia [36]. Suppression of
apoptosis by the neuron could be an adaptation to combat stimuli that pathologically up-regulate endogenous
amyloid. These stimuli, such as perhaps infection with C.
pneumoniae, may indirectly block death of the host cell
through this anti-apoptotic effect, thereby promoting the
obligate intracellular bacterium's ability to replicate
within the host. While inhibiting apoptosis may be favorable to the bacterium, maintaining a chronic or prolonged infection that also up-regulates amyloid could
ultimately lead to chronic disease states. The neuron's tolerance to amyloid is likely to be concentration-dependent

and overwhelming amyloid production and processing
may result in the amyloid pathology characteristic of AD.

Conclusion
In summary, C. pneumoniae readily infects neuroblastoma
cells in vitro and maintains a prolonged infection by
inhibiting apoptosis. As C. pneumoniae also has been demonstrated to infect neurons in AD brains [18,19], the ability to inhibit the apoptotic process could result in longterm infection in situ. Inhibition of apoptosis by suppression of caspase 3/7 activity, and/or by decreasing levels of
active caspase 3, may be mechanisms by which C. pneumoniae can sustain a prolonged infection in the host and
optimize its intracellular environment. Chronic and/or
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chamber slides were incubated at 37°C in 5% CO2 for the
various time points.
Induction of Apoptosis
Uninfected and infected SK-N-MC neuroblastoma cells
grown in chamber slides were induced to undergo apoptosis using staurosporine dissolved in 0.1% dimethylsulfoxide (DMSO), final concentration 1 μM staurosporine
diluted in GM and incubated for 4 hr at 37°C in 5% CO2.
To control for possible affects that DMSO alone might
have on the cell's nuclear integrity, cells were incubated in
0.1% DMSO without staurosporine. Cells were then
washed with HBSS and processed for immunocytochemistry.

Figure 83/7 activity detected by the Apo-ONE assay
Caspase
Caspase 3/7 activity detected by the Apo-ONE assay.
Plotted relative to the increase in activity in uninfected cells
induced by staurosporine, at three timepoints after infection
with C. pneumoniae. Lanes A-H correspond to the conditions
in panels A-H of figure 7. Lanes C, E and G depict decreased
activity relative to uninfected control. Error bars are s.e.m.
for 9 samples of 104 cells from 3 cell culture preparations.

Immunofluorescence (IF)
Cells processed in chamber slides were rinsed with PBS
pH 7.4 followed by fixation in 100% cold MEOH for 5
min or for 30 min in 1% Cytofix (paraformaldehyde)/
Cytoperm (BD Biosciences, San Jose, CA) diluted in PBS.
Cells were rinsed in PBS and blocked with 0.1% TritonX100 diluted in 10% FBS/PBS or blocked with Perm/
Wash buffer (BD Biosciences) for 30 min at room temperature (RT) followed by a PBS rinse.

prolonged infection in the AD brain may promote amyloidogenesis, neuroinflammation, and ultimately pathology found in late-onset sporadic AD. In this way, infection
with C. pneumoniae in neuronal cells could contribute to
the overall neuropathogenesis of this disease.

To verify neuronal phenotype, cells were incubated with
primary antibodies specific for βIII-tubulin (TUJ1, Sigma
Aldrich, St. Louis, MO) diluted in PBS for 1 hr at 37°C.
The cells were then rinsed with PBS prior to incubating the
cells for 1 hr at 37°C with goat anti-mouse secondary antibody at 1:2000 (Alexa Fluor 594, Invitrogen, Carlsbad,
CA).

Methods
Tissue Culture
SK-N-MC neuroblastoma cells (HTB-10, American Type
Culture Collection, Manassas, VA) were propagated in
growth medium (GM) composed of minimum essential
medium (MEM) supplemented with 2 mM L-glutamine,
1.0 mM sodium pyruvate, 0.1 mM non-essential amino
acids, and 10% fetal bovine serum. Hanks balanced salt
solution (HBSS) and 0.05% trypsin-EDTA were used in
the standard protocol for harvesting cells. Cells were incubated at 37°C with 5% CO2.
Infection in Neuronal Cells
SK-N-MC neuroblastoma cells were grown to 1 × 105 confluency in T25 flasks (Corning Inc., Corning, NY) for the
capase assay or in 4 well chamber slides (Nalge Nunc
International, Rochester, NY) for the immunocytochemistry analysis. The cells were inoculated with 1 × 105 IFU of
AR39 strain (ATCC 53592, Manassas, VA) of C. pneumoniae (multiplicity of infection = 1). The flasks containing
3 ml of GM were then centrifuged in a Sorvall Legend RT
at 750 × g for 30 min at 20°C, then 7 ml of GM was added,
or chamber slides were centrifuged at 150 × g for 30 min
at 20°C. Following centrifugation, both the flasks and the

As a marker for chlamydial inclusions, cells were incubated for 1 hr at 37°C at 1:10 with a directly conjugated,
FITC-anti-Chlamydia antibody which also contained
Evans Blue for staining the cytoplasm (IMAGEN, Oxoid
Ltd., Hampshire, UK) or 1:50 with FITC-anti-Chlamydia
antibody (60C19, Fitzgerald, Concord, MA).
Colabeling for active caspase and chlamydial inclusions
was accomplished as follows. Cells were incubated with a
directly conjugated, FITC-anti-Chlamydia antibody
(61C75, Fitzgerald) at 1:50 for 1 hr at 37°C, and incubated at 1:200 for 1 hr at 37°C with rabbit anti-cleaved
caspase-3 (Cell Signaling Technology, Inc., Danvers, MA).
A goat anti-rabbit secondary antibody at 1:2000 (Alexa
Fluor 594, Invitrogen) was used to detect the caspase labeling. The slides were coverslipped using Prolong® Gold
anti-fade reagent with DAPI (Invitrogen).
For visualization of nuclear profiles in apoptosis analysis,
Hoechst dye 33258 (Sigma-Aldrich, St. Louis, MO) was
used at 1:1000.
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Specificity of the secondary antibodies was confirmed by
incubating with the FITC- or rhodamine-conjugated goat
anti-mouse secondary without prior labeling by primary
antibody.
Annexin V-FITC Fluorescence
Infected and uninfected cells grown in chamber slides
were rinsed in PBS and assayed for phosphatidylserine
using the Annexin V-FITC Fluorescence Microscopy Kit
(BD Biosciences, San Jose, CA) according to manufacturer's directions. Following annexin V labeling, the cells
were fixed for 15 minutes in 1% Cytofix (BD Biosciences,
San Jose, CA) diluted in 1× Annexin V Binding Buffer. The
slides were coverslipped using Prolong® Gold anti-fade
reagent with DAPI (Invitrogen).

http://www.biomedcentral.com/1471-2202/9/13

Thermo Labsystems, Philadelphia, PA) for fluorescence
measurement at excitation and emission wavelengths of
490 nm and 520 nm, respectively. Fluorescence readings
were taken at 30 min intervals for 5 hours of reaction
time, during which fluorescence increased monotonically
from the first measurement to the last. Enzymatic activity
for each well was analyzed as the maximal rate of substrate cleavage calculated from the assay's rate of fluorescence increase; the greatest slope occurred 2 to 4 hr after
initiating the assay for all samples. To facilitate interpretation of the data, the activities were normalized to the
change in activity induced by staurosporine in the uninfected cells. The experiment was performed on 3 cultures,
yielding 3 plates for 24, 48 and 72 hour post-infection
time points.

Immunohistochemistry
AD and non AD control brain tissues (Late-onset AD and
age-matched control brains obtained from Medical College of Pennsylvania/Hahnemann/Drexel University
School of Medicine) were deparaffinized through xylenes
and graded alcohols (100% - 70%) followed by a distilled
water rinse. The slides were then washed with PBS, pH 7.4
and incubated in 3% hydrogen peroxide for 5 min followed by a PBS rinse. Samples were incubated in Citra
antigen retrieval buffer (BioGenex, San Ramon, CA) in a
microwave for 30 sec, followed by rinsing in PBS. Samples
were blocked over 30 min in 2% fetal bovine serum (FBS)
diluted in PBS followed by incubation for 1.5 hr at 37°C
in an anti-chlamydial antibody at 1:200 (Biodesign Inc.,
Carmel, NY) diluted in PBS. Subsequently, samples were
rinsed with PBS followed by incubation in a goat anti-rabbit antibody conjugated to alkaline phosphatase red at
1:400 for 1 hr at 37°C. Samples were washed with PBS.
Samples were counterstained with Harris's Hematoxylin
and then rinsed in ddH2O and then PBS for 5 min. Slides
were dehydrated in graded alcohols (70–100%) and
Xylenes and cover-slipped using Permount.

Image Capture
Slides were viewed on a Nikon E800 epifluorescence
microscope. Images were captured with a Spot RT camera
(Diagnostic Instruments, Sterling Heights, MI) and analyzed using Image Pro Plus 4.5 software (Media Cybernetics, Bethesda, MD).

Caspase Assay
Activity of Caspase-3/7 in uninfected and infected SK-NMC cells was assayed with the Apo-ONE Homogeneous
Caspase-3/7 Assay (Promega, Madison, WI) according to
manufacturer's directions. 105 cells were incubated in
growth media with either 1 μM staurosporine to induce
apoptosis or with the DMSO vehicle for 4 hr at 37°C in
5% CO2. The cells were washed with PBS then brought up
to 1 ml final volume in PBS. The vials were frozen at 20°C to ensure cell lysis. After the cells were thawed, 100
μl aliquots (1 × 104 cells) were pipetted into a 96-well
plate with optical bottom (Nunc 165305) and the ApoONE reagent was added at 1:1 to each well; each condition was tested in triplicate by loading 3 wells with the
same materials. The plate was gently mixed for 30 seconds
then placed in the plate reader (Fluoroskan Ascent CF;

CH: immunohistochemistry;
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